Says leverage ratio has improved “meaningfully” since year end 2024. Expects leverage ratio to return to normalized levels over time. Says medical cost trends in-line with expectations.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health says ‘clear opportunities’ for outperformance in FY25
- CVS Health raises FY25 revenue to ‘at least’ $391.5B from ‘at least’ $382.6B
- CVS sees FY25 revenue ‘at least’ $391.5B, consensus $386.77B
- Options Volatility and Implied Earnings Moves Today, July 31, 2025
- CVS Health reports Q2 adjusted EPS $1.81, consensus $1.46